Correlation Between Amylyx Pharmaceuticals and Axsome Therapeutics
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Axsome Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Axsome Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Axsome Therapeutics, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Axsome Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Axsome Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Axsome Therapeutics.
Diversification Opportunities for Amylyx Pharmaceuticals and Axsome Therapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Amylyx and Axsome is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Axsome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axsome Therapeutics and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Axsome Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axsome Therapeutics has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Axsome Therapeutics go up and down completely randomly.
Pair Corralation between Amylyx Pharmaceuticals and Axsome Therapeutics
Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to under-perform the Axsome Therapeutics. In addition to that, Amylyx Pharmaceuticals is 2.33 times more volatile than Axsome Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. Axsome Therapeutics is currently generating about 0.04 per unit of volatility. If you would invest 7,524 in Axsome Therapeutics on August 31, 2024 and sell it today you would earn a total of 2,298 from holding Axsome Therapeutics or generate 30.54% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Amylyx Pharmaceuticals vs. Axsome Therapeutics
Performance |
Timeline |
Amylyx Pharmaceuticals |
Axsome Therapeutics |
Amylyx Pharmaceuticals and Axsome Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Amylyx Pharmaceuticals and Axsome Therapeutics
The main advantage of trading using opposite Amylyx Pharmaceuticals and Axsome Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Axsome Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will offset losses from the drop in Axsome Therapeutics' long position.Amylyx Pharmaceuticals vs. Dogwood Therapeutics, | Amylyx Pharmaceuticals vs. Enlivex Therapeutics | Amylyx Pharmaceuticals vs. Ensysce Biosciences | Amylyx Pharmaceuticals vs. Entero Therapeutics, |
Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |